SLIDE 56 Part D Funds cannot be used for:
- Charges that are billable to third party payors (e.g., private health insurance, prepaid health
plans, Medicaid, Medicare, HUD, other RWHAP funding including ADAP)
- To directly provide housing or health care services (e.g., HIV care, counseling and testing) that
duplicate existing services
- PrEP or non-occupational Post-Exposure Prophylaxis (nPEP) medications or the related medical
- services. As outlined in the June 22, 2016 RWHAP and PrEP program letter, the RWHAP
legislation provides grant funds to be used for the care and treatment of PLWH, thus prohibiting the use of RWHAP funds for PrEP medications or related medical services, such as physician visits and laboratory costs. Cash payments to intended clients of RWHAP services
- Purchase of sterile needles and syringes for the purpose of illegal drug use. Some aspects of
Syringe Services Programs are allowable with HRSA's prior approval and in compliance with HHS and HRSA policy. See https://www.aids.gov/federal-resources/policies/syringe-services- programs/ .
- Purchase or construction of new facilities or capital improvements to existing facilities
- Development of materials designed to promote or encourage, directly, intravenous drug use or
sexual activity, whether homosexual or heterosexual
- Lobbying activities and expenses
Services must be consistent with HAB Policy Clarification Notice 16-02
https://hab.hrsa.gov/sites/default/files/hab/program-grants-management/ServiceCategoryPCN_16-02Final.pdf?
56